Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 3, 1996, Pages 991-996

  Walmrath, Dieter ^a   Schneider, Thomas ^a   Schermuly, Ralph ^a   Olschewski, Horst ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG BLOOD FLOW; MALE; PRIORITY JOURNAL;

EID: 0029880173     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.3.8630585     Document Type: Article

References (29)

1. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
2. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, R. Spragg, and the Consensus Committee. 1994. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-824.
3. Sloane, P. J., M. H. Gee, J. E. Gottlieb, K. H. Albertine, S. P. Peters, J. R. Burns, G. Machiedo, and J. E. Fish. 1992. A multicenter registry of patients with acute respiratory distress syndrome. Am. Rev. Respir. Dis. 146:419-426.
4. Frostell, C., M.-D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. 1991. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047.
5. Rossaint, R., K. J. Falke, F. López, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
6. Wysocki, M., C. Delclaux, E. Roupie, O. Langeron, N. Liu, B. Herman, F. Lemaire, and L. Brochard. 1994. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bimesylate in the adult respiratory distress syndrome. Intensive Care Med. 20: 254-259.
7. Puybasset, L., T. Stewart, J. J. Rouby, P. Cluzel, E. Mourgeon, M. F. Belin, M. Arthaud, C. Landault, and P. Viars. 1994. Inhaled nitric oxide reverses the increases in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 80:1254-1267.
8. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork. 1991. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338:1173-1174.
9. Kinsella, J. P., S. R. Neish, E. Shaffer, and S. H. Abman. 1992. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-820.
10. Moinard, J., G. Manier, O. Pillet, and Y. Castaing. 1994. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 149:1482-1487.
11. Girard, C., J. J. Lehot, and J. C. Pannetier. 1992. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 77:880-883.
12. Adnot, S., C. Kouyoumdjian, C. Defouilloy, P. Andrivet, S. Sediame, R. Herigault, and M. D. Fratacci. 1993. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am. Rev. Respir. Dis. 148:310-316.
13. 1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am. Rev. Respir. Dis. 139:106-116.
14. Radermacher, P., B. Santak, H. J. Wüst, J. Tarnow, and K. J. Falke. 1990. Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS. Intensive Care Med. 16:227-232.
15. Walmrath, D., T. Schneider, J. Pilch, F. Grimminger, and W. Seeger. 1993. Aerosolized prostacyclin reduces pulmonary artery pressure and improves gas exchange in the adult respiratory distress syndrome (ARDS). Lancet 342:961-962.
16. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur. Surg. Res. 25:329-340.
17. Walmrath, D., T. Schneider, J. Pilch, R. Schermully, F. Grimminger, and W. Seeger. 1995. Effects of aerosolized prostacyclin in severe pneumonia impact of fibrosis. Am. J. Respir. Crit. Care Med. 151:724-730.
18. Wagner, P. D., H. A. Saltzman, and J. B. West. 1974. Measurement of continuous distributions of ventilation-perfusion ratios: theory. J. Appl. Physiol. 36:588-599.
19. Gerlach, H., D. Pappert, K. Lewandowski, R. Roissant, and K. Falke. 1993. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med. 19:443-449.
20. Hardy, C. C., P. Bradding, C. Robinson, and S. T. Holgate. 1988. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J. Appl. Physiol. 64:1567-1574.
21. Higgenbottam, T. 1987. The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am. Rev. Respir. Dis. 136:782-785.
22. Ralph, D. D., H. T. Robertson, L. J. Weaver, M. P. Hlastala, C. J. Carrico, and L. D. Hudson. 1985. Distribution of ventilation and perfusion during positive end-expiratory pressure in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 131:54-60.
23. Dantzker, D. R., C. J. Brook, P. Dehart, J. P. Lynch, and J. G. Weg. 1979. Ventilation-perfusion distribution in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 120:1039-1052.
24. Rimar, S., and C. N. Gillis. 1993. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88:2884-2887.
25. Rich, G. F., C. M. Roos, S. M. Anderson, D. C. Urich, M. O. Daugherty, and R. A. Johns. 1993. Inhaled nitric oxide: dose response and the effects of blood in the isolated rat lung. J. Appl. Physiol. 75: 1278-1284.
26. Macnee, W. 1994. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150: 833-852.
27. Grimminger, F., R. Spriestersbach, N. Weissmann, D. Walmrath, and W. Seeger. 1995. Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J. Appl. Physiol. 78:1509-1515.
28. Curtis, J., J. T. O'Neill, and G. Pettett. 1993. Endotracheal administration of tolazoline in hypoxia-induced pulmonary hypertension. Pediatrics 92:403-408.
29. Goris, R. J. A., T. P. A. te Boekhurts, J. K. S. Nuytinck, and J. S. F. Gimbrere. 1985. Multiple-organ failure. Generalized autodestructive inflammation? Arch. Surg. 120:1109-1115. (Reference for organ failure: Table 1.)